Alzheimer's Disease Trial, Recruiting NCT05623124 Sponsor: Ruijin Hospital Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT05623124
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 50 and 90 years old (male or female)
  • You have been diagnosed with mild cognitive impairment or dementia related to Alzheimer's disease, based on recognised medical guidelines
  • Your score on a standard depression questionnaire (called the Hamilton Depression Rating Scale) is below 10, meaning little or no depression
  • Your level of cognitive decline has been rated at 0.5 or higher on a standard memory and thinking assessment (called the Clinical Dementia Rating scale)
  • A neurological check-up has not found any major signs of other nerve-related problems
  • You have a reliable and consistent caregiver who can support you during the trial
  • You completed at least primary school (up to grade 6) and are able to take part in thinking and memory tests and cognitive training activities

Who may not be able to join:

  • Your memory or thinking problems are caused by something other than Alzheimer's, such as stroke, brain infection, Huntington's disease, Parkinson's disease, head injury, alcohol or drug use, liver or lung disease, a brain tumour, thyroid problems, or vitamin deficiencies
  • You have a history of nervous system conditions such as stroke, epilepsy, Parkinson's disease, or optic myelitis
  • You have a psychiatric condition such as schizophrenia, bipolar disorder, major depression, or delirium
  • You have serious or unstable problems with your heart, lungs, liver, kidneys, or blood, or a serious illness such as cancer with a poor outlook
  • You have vision or hearing difficulties that would affect your ability to complete thinking and memory tests
  • You have a history of heavy alcohol use or drug misuse in the past two years
  • The research team feels you may not be able to complete the full study (confirm with trial site)
  • You are unable to have an MRI or PET scan for any reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
22 November 2021
Est. completion
1 October 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

MMSE; Clock drawing test; Complex figure test; AVLT; SDT; TMT; Naming test; Fluency

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov